PREMIER BONE GRAFT HARVESTER

Industry steered left to replace it.

 

Data drove us right to design it.

 
Surgeons_edited_edited.png

ILIAC CREST BONE GRAFT IS THE "GOLD STANDARD"

OSTEOCONDUCTIVE, OSTEOGENIC, OSTEOINDUCTIVE. 

 

Strong Level 1 evidence confirms cancellous iliac bone is the "standard of care" that all other bone grafts are measured.  Evidence shows ICBG had identical fusion success to BMP-2 with fewer complications & adverse events.

 

 

ICBG - NATURAL BIOLOGIC HEALING.  NO DRUGS.  NO SYNTHETICS.  NO NONSENSE.

 

NATURAL AUTOGENOUS BONE HEALING.  STRAIGHT-FORWARD SCIENCE.

Cancellous Architechture

Cells Differentiate & Proliferate

Osteoblasts Remodel Bone

Percutaneous Instrumentation

Minimal Incisional Exposure

NEW Disposable MIS Kits

Simple made easier.

The Quickdraw MIS Bone Harvester is available in new completely disposable kits and contains the necessary instruments to obtain bone through a mini-open 1cm to 2cm incision resulting in a reduction of risk factors.

Percutaneous access not available.

Our classical system consists of universal instrumentation kit and access tools that allow a percutaneous incision to the iliac crest facilitating a reduction of risk factors associated with traditional open techniques.  This contributes to better patient outcomes and improved cosmetic appearance.  Hudson or Jacob's attachment for use with manual or power, or customizable for surgeon preference.

DON'T LET FEAR GET IN THE WAY

“Not only does the minimally invasive ICBG harvesting technique offer the well-established fusion enhancing properties of autograft, it also reduces the feared postoperative course of donor site pain and reduced mobility related to the traditional open approach. The minimally invasive ICBG technique also provides a significant saving in surgical costs compared to use of synthetic grafts. Thus, although further studies comparing long-term outcomes of available bone graft options are still required, minimally invasive ICBG harvesting remains a suitable choice during MIS TLIF.”

- Co-Author Kern Singh commenting to RY Ortho on the study, “Iliac Crest Bone Graft for Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Prospective Analysis of Inpatient Pain, Narcotics Consumption, and Costs,” appears in the September 15, 2018 edition of Spine.

 
Coffee and Magazines

CLINICAL DATA OUTLINES CLEAR ICBG SAFETY & SUPERIORITY

 

Autograft is still the "Gold Standard."  MIS makes it even better.

Autograft is undeniably considered the best bone graft for fusion.  Clinical research demonstrates iliac crest graft is superior to allograft, DBM, TCPs, BMAs, and other bone graft substitutes.  The proof is in the science.  

 

Co-Author E. Carragee summarized four (4) separate FDA regulated, randomized, non-blinded investigational device trials of rhBMP-2 and OP-1 use compared to ICBG for spinal fusion.  The study cited:

  "... no significant increase in back pain scores or functional disability at any time after surgery for those subjects undergoing the ICBG harvesting..."

"...(ICBG) did not appear to affect post-operative pain, function, or occupational activities in the best comparative  trials we have."  

 

(E. Carragee, "Pseudomorbidity in iliac crest bone harvesting: the rise of   rhBMP-2 in short segment posterior lumbar fusion"  The Spine Journal 9 (2009) 873-879

 

The SPORT Study published  in JBJS September 2012 found "no difference in post-operative pain scores for patients with or without autograft harvests." (K. Radcliff, "The Effect of Iliac Crest Autograft on the Outcome of Fusion in the Setting of Degenerative Spondylolisthesis" JBJS  Am 9/2012

 

An independent study conducted with the Quickdraw found that pain with our MIS bone harvester was "non-existent" or "mild enough" that patients didn't know they had a bone graft taken...

(S.Piress, Southern Neuro Society 5/2014)."

 The "Gold Standard" is the standard of care.  Is it yours?

 

Percutaneous Access System (option 1)

Disposable MIS Kits  (option 2)

WHAT HAS EXPERIENCE TAUGHT US?

THE GOLD STANDARD STANDS THE TEST OF TIME.

Sunset Run
Going%20Over%20Data_edited.jpg
X-Ray%20Results_edited.jpg

CLINICAL BENEFITS FOR HEALING

ICBG is well-established as the best bone graft available for fusion.

 

ICBG naturally attracts cells to heal & remodel bone without activation drugs, synthetics, or composite carriers. 

 

MIS techniques permit access with a reduction in risk factors associated with pain & morbidity.

COST EFFECTIVE

ICBG is a fraction of the cost of DBM, allograft, TCP, BMA, Cellular Grafts, & BMP.  

 

Average savings are $2300.00 per level 

per patient vs. BMP

K. SINGH et al, Spine Nov. 2018

"The cost of rhBMP-2 ranges from

$2,500 to $4,500 per level..."

"...increased hospital charges

of 14% to 37% per patient."

E. CARRAGEE et al. Spine 9 2009

ICBG is a Value-Based Care Solution that will impact on your annual case volume expeditures.

*

CPT CODE 20937

BMP & other Drug-activated composites, stem cells, DBMs, allograft chips, local bone, TCP, and other synthetic bone substitutes are not reimbursable.

 

 

ICBG is eligible for CPT #20937.

RVU breakdown:  4.85

WC + PE + ME

 

 RESOURCE WASTE ON BONE GRAFT SUBSTITUTES

STUDY DETAILS CLINICAL & ECONOMIC ADVANTAGES OF MIS ICBG vs. BONE SUBSTITUTES 

SOURCE: AAOS Orthoinfo / OTW- RY Ortho

A new retrospective analysis from Rush University Medical Center in Chicago has tackled the topic of using a minimally invasive approach for iliac crest bone graft harvesting.

 

The study, Iliac Crest Bone Graft for Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Prospective Analysis of Inpatient Pain, Narcotics Consumption, and Costs,” appears in the September 15, 2018 edition of Spine.

Co-author Kern Singh, M.D. co-director of the Minimally Invasive Spine Institute at Rush, explained the rationale behind his study to OTW, “In patients undergoing minimally invasive transforaminal lumbar interbody fusion (MIS TLIF), there is a current debate regarding the utility of iliac crest bone graft (ICBG) versus alternative options such as allografts, synthetic bone grafts, and recombinant bone morphogenetic protein-2 (BMP-2) for enhancing fusion.”

“Although ICBG has been a traditional standard for its superior osteoinductive, osteoconductive, and osteogenic properties, there has been a recent drop in popularity due to fears of postoperative donor site pain and decreased mobility. However, recent advances in spine surgery have afforded a minimally invasive approach for ICBG harvesting which may mitigate previous surgical and clinical disadvantages of the open technique. Thus, it was in our interest to compare the immediate postoperative course and surgical costs of patients receiving either minimally invasive ICBG harvesting or a combination of allograft and BMP-2.”

The authors wrote, “Prospective, consecutive analysis of patients undergoing primary, single-level MIS TLIF with ICBG was compared to a historical cohort of consecutive patients that received BMP-2. Operative characteristics were compared between groups using analysis or independent test for categorical and continuous variables, respectively. Postoperative inpatient pain was measured using the Visual Analog Scale, and inpatient narcotics consumption was quantified as oral morphine equivalents. Outcomes were compared between groups using multivariate regression controlling for preoperative characteristics.

A total of 98 patients were included in this analysis, 49 in each cohort…”

Dr. Singh commented to OTW, “Our investigation demonstrated that although patients undergoing minimally invasive ICBG harvesting have marginal increases in operative time and blood loss, they experience no differences in pain or narcotics consumption immediately after surgery compared to patients receiving allograft and BMP-2.”

 

“Furthermore, the use of ICBG harvest saved over $2,300 in surgical costs on average compared to synthetic bone grafts in our study. Thus, minimally invasive ICBG harvesting offers economic advantages over the use of adjuncts without differences in immediate postoperative clinical recovery. However, before making practice-changing decisions, surgeons should consider long-term outcomes and arthrodesis rates amongst graft options which were

outside the scope of our study.”

“Not only does the minimally invasive ICBG harvesting technique offer the well-established fusion enhancing properties of autograft, it also reduces the feared postoperative course of donor site pain and reduced mobility related to the traditional open approach. The minimally invasive ICBG technique also provides a significant saving in surgical costs compared to use of synthetic grafts. Thus, although further studies comparing long-term outcomes of available bone graft options are still required, minimally invasive ICBG harvesting remains a suitable choice during MIS TLIF.”

 
 

SAFE. SIMPLE. VALUE-BASED CARE.

Surgeon
Never Second Guess Your Decision
 

TESTIMONIALS

Making A Difference Since 1998

"Just wanted to give you an update. As of this morning (24hrs post-op), the patient stated that she has little to no pain at her graft site. To me, that is impressive since that is usually the patients' biggest complaint after surgery."

Jodi S. - RN Spine Service

"Quickdraw is my go-to system for cervical fusions. I have reduced my harvest time by 50% and can obtain bone without complaints from patients. I consider this to be the best bone graft I can get. It's simple and very easy to use."

Dr. Mitchell G. - Spine Surgeon

"Our team has seen a big reduction in our bone graft expense. We are very happy with the Quickdraw and encourage all of our surgeons to switch from using other more expensive bone graft products."

Judy D. - OR Materials Manager

OUR TEAM

Michael O'Neill

Founder & Chief Executive

Garrett deBorst

Vice President of Sales

Bob Maloney

Accounting & Logistics

 
 

CONTACT US

We have been committed to advancing MIS solutions since 1997. 

Our team is available to service your needs and can be reached at 888-698-7778.  Or, submit your contact information including email, phone number, and a message regarding your needs, and we will promptly respond.

Thank you.

800 Hingham St, Rockland, MA 02370, USA

ISO 13485/16 Certified

(781) 982-9950

Schedule Zoom Consultation

Susan O'Neill

Administration

Matthew O'Neill

Clinical Field Specialist

 
FUSION...FAST FORWARD

(781) 982-9950

800 Hingham St, Rockland, MA 02370, USA

ISO 13485/16 Certified

PROUDLY MADE IN USA  

 

                                                                                      

©2020 by Paradigm Biodevices Inc. Patents Pending. All Rights Reserved.